Mitochondrial iron metabolism and sideroblastic anemia

Acta Haematologica

Volumn 122, Issue 2-3, 2009, Pages 120-133

  Sheftel, Alex D ^a   Richardson, Des R ^b   Prchal, Josef ^c   Ponka, Prem ^d,e  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF UTAH   (United States)

^d MCGILL UNIVERSITY   (Canada)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

ABCB7; ALAS2; Mitochondrial iron metabolism; Ring sideroblasts; Sideroblastic anemias; Transferrin

Indexed keywords

FERRITIN; IRON CHELATING AGENT; IRON SULFUR PROTEIN; PYRIDOXINE;

ATAXIA; BIOSYNTHESIS; CLINICAL FEATURE; COPPER DEFICIENCY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ERYTHROCYTE TRANSFUSION; ERYTHROID CELL; GENE MUTATION; HUMAN; IRON METABOLISM; IRON OVERLOAD; IRON TRANSPORT; MITOCHONDRIAL GENE; MYELODYSPLASTIC SYNDROME; PATHOGENESIS; PHLEBOTOMY; PRIORITY JOURNAL; REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS; REVIEW; SIDEROBLASTIC ANEMIA; X CHROMOSOME; X LINKED SIDEROBLASTIC ANEMIA;

ANEMIA, SIDEROBLASTIC; ANIMALS; BIOLOGICAL TRANSPORT; HOMEOSTASIS; HUMANS; IRON; MITOCHONDRIA;

EID: 70450216042     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000243796     Document Type: Review

References (67)

1. Napier I, Ponka P, Richardson DR: Iron trafficking in the mitochondrion: novel pathways revealed by disease. Blood 2005; 105: 1867-1874.
2. Prchal JT, Throckmorton DW, Carroll AJ III, Fuson EW, Gams RA, Prchal JF: A common progenitor for human myeloid and lymphoid cells. Nature 1978; 274: 590-591.
3. Beutler E: Hereditary and acquired sideroblastic anemias; in Lichtman MA, Kipps TJ, Kaushansky K, Beutler E, Sleigsohn U, Prchal JT (eds): Williams Hematology. New York, McGraw-Hill, 2005, pp 823-828.
4. Camaschella C, Campanella A, De Falco L, Boschetto L, Merlini R, Silvestri L, Levi S, Iolascon A: The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload. Blood 2007; 110: 1353-1358.
5. Guernsey DL, Jiang H, Campagna DR, Evans SC, Ferguson M, Kellogg MD, Lachance M, Matsuoka M, Nightingale M, Rideout A, Saint-Amant L, Schmidt PJ, Orr A, Bottomley SS, Fleming MD, Ludman M, Dyack S, Fernandez CV, Samuels ME: Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia. Nat Genet 2009; 41: 651-653.
6. Fleming MD: The genetics of inherited sideroblastic anemias. Semin Hematol 2002; 39: 270-281.
7. Camaschella C: Recent advances in the understanding of inherited sideroblastic anaemia. Br J Haematol 2008; 143: 27-38.
8. Bottomley SS: Sideroblastic anemias; in Greer JP, Foerster GM, Paraskevas F, Glader B, Arber DA, Means RT Jr (eds): Wintrobe's Clinical Hematology. Philadelphia, Wolters Kluwer/Lippincott, Williams & Wilkins, 2009, pp 835-856.
9. Richardson DR, Ponka P: The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochim Biophys Acta 1997; 1331: 1-40. (Pubitemid 27168147)
10. Wrighting DM, Andrews NC: Iron homeostasis and erythropoiesis. Curr Top Dev Biol 2008; 82: 141-167.
11. Ohgami RS, Campagna DR, Greer EL, Antiochos B, McDonald A, Chen J, Sharp JJ, Fujiwara Y, Barker JE, Fleming MD: Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells. Nat Genet 2005; 37: 1264-1269.
12. Mims MP, Prchal JT: Divalent metal transporter 1. Hematology 2005; 4: 339-345.
13. Breuer W, Shvartsman M, Cabantchik ZI: Intracellular labile iron. Int J Biochem Cell Biol 2008; 40: 350-354.
14. Richardson DR, Ponka P, Vyoral D: Distribution of iron in reticulocytes after inhibition of heme synthesis with succinylacetone: examination of the intermediates involved in iron metabolism. Blood 1996; 87: 3477-3488.
15. Ponka P: Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood 1997; 89: 1-25.
16. Sheftel AD, Zhang AS, Brown C, Shirihai OS, Ponka P: Direct interorganellar transfer of iron from endosome to mitochondrion. Blood 2007; 110: 125-132.
17. Whitnall M, Rahmanto YS, Sutak R, Xu X, Becker EM, Mikhael MR, Ponka P, Richardson DR: The MCK mouse heart model of Friedreich's ataxia: alterations in iron-regulated proteins and cardiac hypertrophy are limited by iron chelation. Proc Natl Acad Sci USA 2008; 105: 9757-9762.
18. De Domenico I, McVey Ward D, Kaplan J: Regulation of iron acquisition and storage: consequences for iron-linked disorders. Nat Rev Mol Cell Biol 2008; 9: 72-81.
19. Muckenthaler MU, Galy B, Hentze MW: Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/ IRP) regulatory network. Annu Rev Nutr 2008; 28: 197-213.
20. Meyron-Holtz EG, Ghosh MC, Iwai K, La- Vaute T, Brazzolotto X, Berger UV, Land W, Ollivierre-Wilson H, Grinberg A, Love P, Rouault TA: Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis. EMBO J 2004; 23: 386-395.
21. Cox TC, Bawden MJ, Martin A, May BK: Human erythroid 5-aminolevulinate synthase: promoter analysis and identification of an iron-responsive element in the mRNA. EMBO J 1991; 10: 1891-1902.
22. Lok CN, Ponka P: Identification of an erythroid active element in the transferrin receptor gene. J Biol Chem 2000; 275: 24185-24190.
23. Nemeth E, Ganz T: Regulation of iron metabolism by hepcidin. Annu Rev Nutr 2006; 26: 323-342.
24. Peslova G, Petrak J, Kuzelova K, Hrdy I, Halada P, Kuchel PW, Soe-Lin S, Ponka P, Sutak R, Becker E, Huang ML, Rahmanto YS, Richardson DR, Vyoral D: Hepcidin, the hormone of iron metabolism, is bound specifically to alpha-2-macroglobulin in blood. Blood 2009; 113: 6225-6236.
25. Knutson M, Wessling-Resnick M: Iron metabolism in the reticuloendothelial system. Crit Rev Biochem Mol Biol 2003; 38: 61-88.
26. Ajioka RS, Phillips JD, Kushner JP: Biosynthesis of heme in mammals. Biochim Biophys Acta 2006; 1763: 723-736.
27. Lill R, Mühlenhoff U: Maturation of ironsulfur proteins in eukaryotes: mechanisms, connected processes, and diseases. Annu Rev Biochem 2008; 77: 669-700.
28. Biederbick A, Stehling O, Rosser R, Niggemeyer B, Nakai Y, Elsässer HP, Lill R: Role of human mitochondrial Nfs1 in cytosolic iron-sulfur protein biogenesis and iron regulation. Mol Cell Biol 2006; 26: 5675-5687.
29. Stehling O, Elsässer HP, Bruckel B, Mühlenhoff U, Lill R: Iron-sulfur protein maturation in human cells: evidence for a function of frataxin. Hum Mol Genet 2004; 13: 3007-3015.
30. Wingert RA, Galloway JL, Barut B, Foott H, Fraenkel P, Axe JL, Weber GJ, Dooley K, Davidson AJ, Schmid B, Paw BH, Shaw GC, Kingsley P, Palis J, Schubert H, Chen O, Kaplan J, Zon LI: Deficiency of glutaredoxin 5 reveals Fe-S clusters are required for vertebrate haem synthesis. Nature 2005; 436: 1035-1039.
31. Sheftel AD, Lill R: The power plant of the cell is also a smithy: the emerging role of mitochondria in cellular iron homeostasis. Ann Med 2009; 41: 82-99.
32. Levi S, Corsi B, Bosisio M, Invernizzi R, Volz A, Sanford D, Arosio P, Drysdale J: A human mitochondrial ferritin encoded by an intronless gene. J Biol Chem 2001; 276: 24437-24440.
33. Cazzola M, Invernizzi R, Bergamaschi G, Levi S, Corsi B, Travaglino E, Rolandi V, Biasiotto G, Drysdale J, Arosio P: Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia. Blood 2003; 101: 1996-2000.
34. Shaw GC, Cope JJ, Li L, Corson K, Hersey C, Ackermann GE, Gwynn B, Lambert AJ, Wingert RA, Traver D, Trede NS, Barut BA, Zhou Y, Minet E, Donovan A, Brownlie A, Balzan R, Weiss MJ, Peters LL, Kaplan J, Zon LI, Paw BH: Mitoferrin is essential for erythroid iron assimilation. Nature 2006; 440: 96-100.
35. Shaw GC, Longer NB, Wang YM, Li LT, Kaplan J, Bloomer JR, Paw BH: Abnormal expression of human mitoferrin (SLC25A37) is associated with a variant of erythropoietic protoporphyria. Blood 2006; 108: 6A.
36. Shepherd M, Dailey TA, Dailey HA: A new class of [2Fe-2S]-cluster- containing protoporphyrin (IX) ferrochelatases. Biochem J 2006; 397: 47-52.
37. Whatley SD, Ducamp S, Gouya L, Grandchamp B, Beaumont C, Badminton MN, Elder GH, Holme SA, Anstey AV, Parker M, Corrigall AV, Meissner PN, Hift RJ, Marsden JT, Ma Y, Mieli-Vergani G, Deybach JC, Puy H: C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload. Am J Hum Genet 2008; 83: 408-414.
38. Cavadini P, Biasiotto G, Poli M, Levi S, Verardi R, Zanella I, Derosas M, Ingrassia R, Corrado M, Arosio P: RNA silencing of the mitochondrial ABCB7 transporter in HeLa cells causes an iron-deficient phenotype with mitochondrial iron overload. Blood 2007; 109: 3552-3559.
39. Bekri S, Kispal G, Lange H, Fitzsimons E, Tolmie J, Lill R, Bishop DF: Human ABC7 transporter: gene structure and mutation causing X-linked sideroblastic anemia with ataxia with disruption of cytosolic iron-sulfur protein maturation. Blood 2000; 96: 3256-3264.
40. Pondarré C, Antiochos BB, Campagna DR, Clarke SL, Greer EL, Deck KM, McDonald A, Han AP, Medlock A, Kutok JL, Anderson SA, Eisenstein RS, Fleming MD: The mitochondrial ATP-binding cassette transporter Abcb7 is essential in mice and participates in cytosolic iron-sulfur cluster biogenesis. Hum Mol Genet 2006; 15: 953-964.
41. Pondarré C, Campagna DR, Antiochos B, Sikorski L, Mulhern H, Fleming MD: Abcb7, the gene responsible for X-linked sideroblastic anemia with ataxia, is essential for hematopoiesis. Blood 2007; 109: 3567-3569.
42. Rademakers LH, Koningsberger JC, Sorber CW, Baart de la Faille H, Van Hattum J, Marx JJ: Accumulation of iron in erythroblasts of patients with erythropoietic protoporphyria. Eur J Clin Invest 1993; 23: 130-138.
43. Luk E, Carroll M, Baker M, Culotta VC: Manganese activation of superoxide dismutase in Saccharomyces cerevisiae requires MTM1, a member of the mitochondrial carrier family. Proc Natl Acad Sci USA 2003; 100: 10353-10357.
44. Yang M, Cobine PA, Molik S, Naranuntarat A, Lill R, Winge DR, Culotta VC: The effects of mitochondrial iron homeostasis on cofactor specificity of superoxide dismutase 2. EMBO J 2006; 25: 1775-1783.
45. Zhang AS, Sheftel AD, Ponka P: Intracellular kinetics of iron in reticulocytes: evidence for endosome involvement in iron targeting to mitochondria. Blood 2005; 105: 368-375.
46. Munakata H, Sun JY, Yoshida K, Nakatani T, Honda E, Hayakawa S, Furuyama K, Hayashi N: Role of the heme regulatory motif in the heme-mediated inhibition of mitochondrial import of 5-aminolevulinate synthase. J Biochem 2004; 136: 233-238.
47. Furuyama K, Sassa S: Interaction between succinyl CoA synthetase and the heme-biosynthetic enzyme ALAS-E is disrupted in sideroblastic anemia. J Clin Invest 2000; 105: 757-764.
48. Furuyama K, Sassa S: Multiple mechanisms for hereditary sideroblastic anemia. Cell Mol Biol (Noisy-le-grand) 2002; 48: 5-10.
49. Astner I, Schulze JO, van den Heuvel J, Jahn D, Schubert WD, Heinz DW: Crystal structure of 5-aminolevulinate synthase, the first enzyme of heme biosynthesis, and its link to XLSA in humans. EMBO J 2005; 24: 3166-3177.
50. Lill R, Dutkiewicz R, Elsässer H-P, Hausmann A, Netz DJA, Pierik AJ, Stehling O, Urzica E, Mühlenhoff U: Mechanisms of iron-sulfur protein maturation in mitochondria, cytosol and nucleus of eukaryotes. Biochim Biophys Acta 2006; 1763: 652-667. (Pubitemid 44189544)
51. Allikmets R, Raskind WH, Hutchinson A, Schueck ND, Dean M, Koeller DM: Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA/A). Hum Mol Genet 1999; 8: 743-749.
52. Gattermann N: From sideroblastic anemia to the role of mitochondrial DNA mutations in myelodysplastic syndromes. Leuk Res 2000; 24: 141-151.
53. Shin MG, Kajigaya S, Levin BC, Young NS: Mitochondrial DNA mutations in patients with myelodysplastic syndromes. Blood 2003; 101: 3118-3125.
54. Boultwood J, Pellagatti A, Nikpour M, Pushkaran B, Fidler C, Cattan H, Littlewood TJ, Malcovati L, Della Porta MG, Jadersten M, Killick S, Giagounidis A, Bowen D, Hellstrom-Lindberg E, Cazzola M, Wainscoat JS: The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts. PLoS ONE 2008; 3:e1970.
55. Hall R, Losowsky MS: The distribution of erythroblast iron in sideroblastic anaemias. Br J Haematol 1966; 12: 334-340.
56. Pearson HA, Lobel JS, Kocoshis SA, Naiman JL, Windmiller J, Lammi AT, Hoffman R, Marsh JC: A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatr 1979; 95: 976-984.
57. Bykhovskaya Y, Casas K, Mengesha E, Inbal A, Fischel-Ghodsian N: Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am J Hum Genet 2004; 74: 1303-1308.
58. Mufti GJ, Bennett JM, Goasguen J, Bain BJ, Baumann I, Brunning R, Cazzola M, Fenaux P, Germing U, Hellstrom-Lindberg E, Jinnai I, Manabe A, Matsuda A, Niemeyer CM, Sanz G, Tomonaga M, Vallespi T, Yoshimi A: Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts. Haematologica 2008; 93: 1712-1717.
59. Jones RL, Homa DM, Meyer PA, Brody DJ, Caldwell KL, Pirkle JL, Brown MJ: Trends in blood lead levels and blood lead testing among US children aged 1 to 5 years, 1988- 2004. Pediatrics 2009; 123:e376-e385.
60. Bradman A, Eskenazi B, Sutton P, Athanasoulis M, Goldman LR: Iron deficiency associated with higher blood lead in children living in contaminated environments. Environ Health Perspect 2001; 109: 1079-1084.
61. Pagliuca A, Mufti GJ, Baldwin D, Lestas AN, Wallis RM, Bellingham AJ: Lead poisoning: clinical, biochemical, and haematological aspects of a recent outbreak. J Clin Pathol 1990; 43: 277-281.
62. Gregg XT, Reddy V, Prchal JT: Copper deficiency masquerading as myelodysplastic syndrome. Blood 2002; 100: 1493-1495.
63. Yu Y, Kalinowski D, Kovacevic Z, Siafakas R, Jansson P, Stefani C, Lovejoy DB, Sharpe PC, Bernhard, PV, Richardson DR: Thiosemicarbazones from the old to new: iron chelators that are more than just ribonucleotide reductase inhibitors. J Med Chem 2009;52: 5271-5294.
64. Verma A, Nye JS, Snyder SH: Porphyrins are endogenous ligands for the mitochondrial (peripheral-type) benzodiazepine receptor. Proc Natl Acad Sci USA 1987; 84: 2256-2260.
65. Krishnamurthy PC, Du G, Fukuda Y, Sun D, Sampath J, Mercer KE, Wang J, Sosa-Pineda B, Murti KG, Schuetz JD: Identification of a mammalian mitochondrial porphyrin transporter. Nature 2006; 443: 586-589.
66. Jacob BB, Dailey TA, Lianchun X, Dailey HA: Characterization of a human and mouse tetrapyrrole-binding protein. Arch Biochem Biophys 2002; 407: 196-201.
67. Huang MLH, Becker EM, Whitnall M, Rahmanto YS, Ponka P, Richardson DR: Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant. Proc Natl Acad Sci USA 2009;106:16381-16386.